Blog
RSS FeedPosted by Michael Wonder on 07 Jun 2021
Post-market review of medicines for smoking cessation – public consultation on the draft report
7 June 2021 - The draft report for the post-market review of medicines for smoking cessation is available for public comment ...
Posted by Michael Wonder on 28 May 2021
Post-market review of opiate dependence treatment program medicines
28 May 2021 - On 24 March 2021 it was announced the Department of Health will conduct a post-market review ...
Posted by Michael Wonder on 24 Mar 2021
Post-market review of medicines available on the PBS Opiate Dependence Treatment Program
24 March 2021 - The Department of Health will conduct a post-market review of the medicines available under the Pharmaceutical ...
Posted by Michael Wonder on 15 Feb 2021
Post-market review of medicines for smoking cessation – stakeholder forum outcome
15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...
Posted by Michael Wonder on 21 Dec 2020
Closure of the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
21 December 2020 - A plain language summary for the post-market review of the use of biologics in the treatment ...
Posted by Michael Wonder on 09 Nov 2020
Post-market review of medicines for smoking cessation – targeted stakeholder forum
9 November 2020 - A Stakeholder Forum will be held via webinar for the post-market review of medicines for smoking cessation ...
Posted by Michael Wonder on 25 May 2020
Final report for the post-market review of pulmonary arterial hypertension medicines
25 May 2020 - The final report and outcomes of the post-market review of pulmonary arterial hypertension medicines are now publicly ...
Posted by Michael Wonder on 13 Mar 2020
Final terms of reference and public consultation to the post-market review of medicines for smoking cessation
13 March 2020 - The final terms of reference of the post-market review of medicines for smoking cessation are now ...
Posted by Michael Wonder on 24 Oct 2019
Post-market review of medicines for smoking cessation
24 October 2019 - A public consultation process for the post-market review of medicines for smoking cessation will be open ...
Posted by Michael Wonder on 17 Aug 2018
Post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
17 August 2018 - The PBAC minutes pertaining to the draft review report for the post-market review of the use of ...
Posted by Michael Wonder on 21 May 2018
Draft report for the post-market review of medicines for pulmonary arterial hypertension
21 May 2018 - The draft report for the post-market review of medicines for pulmonary arterial hypertension is available for public ...
Posted by Michael Wonder on 30 Jan 2018
Post-market review of chronic obstructive pulmonary disease medicines – final report released
30 January 2018 - The final report and outcomes of the post-market review of chronic obstructive pulmonary disease medicines is now ...
Posted by Michael Wonder on 18 Jan 2018
Draft report for the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
18 January 2018 - The draft report for the post-market review of the use of biologics in the treatment of severe ...
Posted by Michael Wonder on 20 Dec 2017
Post-market review of ezetimibe - final report
20 December 2017 - The final report for the post-market review of ezetimibe and PBAC recommendations for the post-market review of ...
Posted by Michael Wonder on 08 Dec 2017
Consumer outcome statement for the post-market review of PAH medicines
8 December 2017 - A consumer session was held with patients with PAH and their carers during the PHAA Members Carers ...